Evaluation of the Capilia TB assay for culture confirmation of Mycobacterium tuberculosis infections in Zambia and South Africa

Journal of Clinical Microbiology

Volumn 48, Issue 10, 2010, Pages 3773-3775

  Muyoyeta, Monde ^a   De Haas, Petra E W ^a,b   Mueller, Dirk H ^b   Van Helden, Paul D ^c   Mwenge, Lawrence ^a   Schaap, Ab ^a,b   Kruger, Clarissa ^c   Van Pittius, Nicolaas C Gey ^c   Lawrence, Katherine ^c   Beyers, Nulda ^c   Godfrey Faussett, Peter ^b   Ayles, Helen ^a,b  

^a UNIVERSITY OF ZAMBIA   (Zambia)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BIOASSAY; CAPILIA TB ASSAY; COST UTILITY ANALYSIS; CULTURE TECHNIQUE; LIQUID CULTURE; MYCOBACTERIUM; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM GORDONAE; MYCOBACTERIUM INTERJECTUM; MYCOBACTERIUM INTRACELLULARE; MYCOBACTERIUM KANSASII; MYCOBACTERIUM MALMOENSE; MYCOBACTERIUM PEREGRINUM; MYCOBACTERIUM SCROFULACEUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; TUBERCULOSIS; ZAMBIA;

BACTERIOLOGICAL TECHNIQUES; HUMANS; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; TIME FACTORS; TUBERCULOSIS; ZAMBIA;

MYCOBACTERIUM TUBERCULOSIS;

EID: 77957809915     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01688-09     Document Type: Article

References (19)

1. Abe, C., K. Hirano, and T. Tomiyama. 1999. Simple and rapid identification of the Mycobacterium tuberculosis complex by immunochromatographic assay using anti-MPB64 monoclonal antibodies. J. Clin. Microbiol. 37:3693-3697.
2. Alcaide, F., M. A. Benitez, J. M. Escriba, and R. Martin. 2000. Evaluation of the BACTEC MGIT 960 and the MB/BacT systems for recovery of mycobacteria from clinical specimens and for species identification by DNA AccuProbe. J. Clin. Microbiol. 38:398-401.
3. Ayles, H., A. Schaap, A. Nota, C. Sismanidis, R. Tembwe, P. De Haas, M. Muyoyeta, and N. Beyers. 2009. Prevalence of tuberculosis, HIV and respiratory symptoms in two Zambian communities: implications for tuberculosis control in the era of HIV. PLoS One 4:e5602.
4. Casal, M., J. Gutierrez, and M. Vaquero. 1997. Comparative evaluation of the mycobacteria growth indicator tube with the BACTEC 460 TB system and Lowenstein-Jensen medium for isolation of mycobacteria from clinical specimens. Int. J. Tuberc. Lung Dis. 1:81-84.
5. Cruciani, M., C. Scarparo, M. Malena, O. Bosco, G. Serpelloni, and C. Mengoli. 2004. Meta-analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without solid media, for detection of mycobacteria. J. Clin. Microbiol. 42:2321-2325.
6. Hillemann, D., S. Rusch-Gerdes, and E. Richter. 2005. Application of the Capilia TB assay for culture confirmation of Mycobacterium tuberculosis complex isolates. Int. J. Tuberc. Lung Dis. 9:1409-1411.
7. Hirano, K., A. Aono, M. Takahashi, and C. Abe. 2004. Mutations including IS6110 insertion in the gene encoding the MPB64 protein of Capilia TB-negative Mycobacterium tuberculosis isolates. J. Clin. Microbiol. 42:390-392.
8. Huang, T. S., C. S. Chen, S. S. Lee, W. K. Huang, and Y. C. Liu. 2001. Comparison of the BACTEC MGIT 960 and BACTEC 460TB systems for detection of mycobacteria in clinical specimens. Ann. Clin. Lab. Sci. 31:279-283.
9. Kent, P. T., and G. P. Kubica. 1985. Public health mycobacteriology: a guide for the level III laboratory. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA.
10. Mueller, D. H., L. Mwenge, M. Muyoyeta, M. W. Muvwimi, R. Tembwe, R. McNerney, P. Godfrey-Faussett, and H. M. Ayles. 2008. Costs and cost-effectiveness of tuberculosis cultures using solid and liquid media in a developing country. Int. J. Tuberc. Lung Dis. 12:1196-1202.
11. Muyoyeta, M., J. A. Schaap, P. De Haas, W. Mwanza, M. W. Muvwimi, P. Godfrey-Faussett, and H. Ayles. 2009. Comparison of four culture systems for Mycobacterium tuberculosis in the Zambian National Reference Laboratory. Int. J. Tuberc. Lung Dis. 13:460-465.
12. Ngamlert, K., C. Sinthuwattanawibool, K. D. McCarthy, H. Sohn, A. Starks, P. Kanjanamongkolsiri, R. Anek-vorapong, T. Tasaneeyapan, P. Monkongdee, L. Diem, and J. K. Varma. 2009. Diagnostic performance and costs of Capilia TB for Mycobacterium tuberculosis complex identification from broth-based culture in Bangkok, Thailand. Trop. Med. Int. Health 14:748-753.
13. Perkins, M. D., and J. Cunningham. 2007. Facing the crisis: improving the diagnosis of tuberculosis in the HIV era. J. Infect. Dis. 196(Suppl. 1):S15-S27.
14. Siddiqi, S. H., and S. Rüsch-Gerdes. 2006. MGIT procedure manual for Bactec MGIT 960 TB system. Foundation for Innovative New Diagnostics, Geneva, Switzerland.
15. Scarparo, C., P. Piccoli, A. Rigon, G. Ruggiero, P. Ricordi, and C. Piersimoni. 2002. Evaluation of the BACTEC MGIT 960 in comparison with BACTEC 460 TB for detection and recovery of mycobacteria from clinical specimens. Diagn. Microbiol. Infect. Dis. 44:157-161.
16. Shen, G. H., C. H. Chen, C. H. Hung, K. M. Wu, C. F. Lin, Y. W. Sun, and J. H. Chen. 2009. Combining the Capilia TB assay with smear morphology for the identification of Mycobacterium tuberculosis complex. Int. J. Tuberc. Lung Dis. 13:371-376.
17. Somoskovi, A., and P. Magyar. 1999. Comparison of the mycobacteria growth indicator tube with MB redox, Lowenstein-Jensen, and Middlebrook 7H11 media for recovery of mycobacteria in clinical specimens. J. Clin. Microbiol. 37:1366-1369.
18. Wang, J. Y., L. N. Lee, H. C. Lai, H. L. Hsu, I. S. Jan, C. J. Yu, P. R. Hsueh, and P. C. Yang. 2007. Performance assessment of the Capilia TB assay and the BD ProbeTec ET system for rapid culture confirmation of Mycobacterium tuberculosis. Diagn. Microbiol. Infect. Dis. 59:395-399.
19. World Health Organization. 2006. Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents: recommendations for HIV-prevalent and resource-constrained settings. World Health Organization, Geneva, Switzerland.